Clinical Trials Browser

Phase 3 × Non-Squamous Non-small Cell Lung Cancer × 90 days × Clear all

NCT06396065 2026-03-24

Phase III Study of AK112 for NSCLC Patients

Phase 3 Active not recruiting

Non-Squamous Non-small Cell Lung Cancer